Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 5
2017 6
2018 6
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA. Ballantyne CM, et al. Atherosclerosis. 2018 Oct;277:195-203. doi: 10.1016/j.atherosclerosis.2018.06.002. Epub 2018 Jun 12. Atherosclerosis. 2018. PMID: 29910030 Free article. Clinical Trial.
Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease.
Goldstein KM, Stechuchak KM, Zullig LL, Oddone EZ, Olsen MK, McCant FA, Bastian LA, Batch BC, Bosworth HB. Goldstein KM, et al. Version 2. J Womens Health (Larchmt). 2017 Jul;26(7):806-814. doi: 10.1089/jwh.2016.5739. Epub 2017 Feb 13. J Womens Health (Larchmt). 2017. PMID: 28192012 Free PMC article.
LDL cholesterol levels after switch from atorvastatin to rosuvastatin.
Lewis SJ, Olufade T, Anzalone DA, Malangone-Monaco E, Evans KA, Johnston S. Lewis SJ, et al. Curr Med Res Opin. 2018 Oct;34(10):1717-1723. doi: 10.1080/03007995.2017.1421147. Epub 2018 Feb 21. Curr Med Res Opin. 2018. PMID: 29271267
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy.
Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P. Jetty V, et al. Vasc Health Risk Manag. 2017 Jul 6;13:247-253. doi: 10.2147/VHRM.S133690. eCollection 2017. Vasc Health Risk Manag. 2017. PMID: 28740397 Free PMC article.
Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND, Young D, Zhao Y, Nguyen H, Caballes J, Khan I, Sanchez RJ. Wong ND, et al. J Clin Lipidol. 2016 Sep-Oct;10(5):1109-18. doi: 10.1016/j.jacl.2016.06.011. Epub 2016 Jun 29. J Clin Lipidol. 2016. PMID: 27678427
Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin.
Fazio S, Robertson DG, Joh T, Wan H, Riel T, Forgues P, Baum CM, Garzone PD, Gumbiner B. Fazio S, et al. Cardiovasc Ther. 2018 Feb;36(1). doi: 10.1111/1755-5922.12308. Epub 2017 Nov 25. Cardiovasc Ther. 2018. PMID: 29057618 Free article. Clinical Trial.
Use of Complementary Health Approaches Among Diverse Primary Care Patients with Type 2 Diabetes and Association with Cardiometabolic Outcomes: From the SF Bay Collaborative Research Network (SF Bay CRN).
Handley MA, Quan J, Chao MT, Ratanawongsa N, Sarkar U, Emmons-Bell S, Schillinger D. Handley MA, et al. J Am Board Fam Med. 2017 Sep-Oct;30(5):624-631. doi: 10.3122/jabfm.2017.05.170030. J Am Board Fam Med. 2017. PMID: 28923815 Free article.
21 results
Jump to page